A novel iduronate-2-sulfatase fused with a TfR1 mAb based on the technology called J-Brain Cargo® can penetrate BBB and treat mucopolysaccharidosis II (MPS II) efficiently (NCT03128593) [103]. Here, TFRC is linked to mucopolysaccharidosis type 2.